| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |